Sepsis
-
Business & Markets · Startups Inflammatix Secures $57M to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
Insider Brief Inflammatix closed a $57 million Series E round, led by Khosla Ventures and Think.Health, to support regulatory filing and commercialization of its TriVerity™ Sepsis Test. TriVerity, a blood test designed for emergency… -
Business & Markets · Enterprise Emory Awarded Funding to Test AI Use in Sepsis Patients Through Precision Medicine Approach
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.